Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0WTELA
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
WO2023173132A1 ADC-17
|
|||||
| Synonyms |
ADC-17
Click to Show/Hide
|
|||||
| Organization |
REGENERON PHARMACEUTICALS, INC.
|
|||||
| Drug Status |
Investigative
|
|||||
| Drug-to-Antibody Ratio |
2.9
|
|||||
| Antibody Name |
undisclosed
|
|||||
| Antigen Name |
Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)
|
Antigen Info | ||||
| Payload Name |
P9
|
Payload Info | ||||
| Linker Name |
Undisclosed
|
|||||
| Conjugate Type |
site-specific conjugation
|
|||||
| Combination Type |
DIBAC-suc-G4S-P9
|
|||||